MarkWide Research

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 310-961-4489

24/7 Customer Support

All our reports can be tailored to meet our clients’ specific requirements, including segments, key players and major regions,etc.

Global Sepsis Diagnostics Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2024-2032

Published Date: January, 2024
Base Year: 2023
Delivery Format: PDF+ Excel
Historical Year: 2017-2023
No of Pages: 263
Forecast Year: 2024-2032

Corporate User License


Market Overview

The global sepsis diagnostics market refers to the market for diagnostic tools and tests used in the detection and monitoring of sepsis, a life-threatening condition caused by the body’s response to infection. Sepsis is a serious health concern worldwide, leading to millions of deaths each year. Early and accurate diagnosis of sepsis is crucial for effective treatment and patient outcomes.


Sepsis is a medical condition characterized by a systemic inflammatory response to infection. It occurs when the body’s immune system overreacts to an infection and starts attacking its own tissues and organs. Sepsis can progress rapidly and may lead to organ failure, septic shock, and death if not promptly diagnosed and treated.

Executive Summary

The global sepsis diagnostics market is witnessing significant growth due to the increasing incidence of sepsis cases globally. The market is driven by factors such as the rising prevalence of infections, growing awareness about sepsis among healthcare professionals, and technological advancements in diagnostic techniques. However, the market also faces challenges such as the high cost of diagnostic tests and the lack of skilled professionals in certain regions.

Global Sepsis Diagnostics Market

Key Market Insights

  1. Growing incidence of sepsis: The global sepsis diagnostics market is driven by the increasing number of sepsis cases worldwide. Factors such as the aging population, the rise in antibiotic-resistant infections, and the high prevalence of hospital-acquired infections contribute to the growing incidence of sepsis.
  2. Technological advancements: The market is witnessing significant technological advancements in sepsis diagnostic tools and tests. Innovative techniques such as molecular diagnostics, biomarkers, and point-of-care testing are improving the accuracy and speed of sepsis diagnosis, thereby driving market growth.
  3. Increasing awareness: There is a growing awareness among healthcare professionals about the importance of early sepsis diagnosis. Initiatives by organizations such as the Global Sepsis Alliance and the World Health Organization have helped in increasing awareness about sepsis and its diagnostic methods, leading to a higher demand for sepsis diagnostic products.
  4. High cost of diagnostic tests: One of the major challenges in the sepsis diagnostics market is the high cost associated with diagnostic tests. The cost of advanced diagnostic techniques and tests can be a barrier, especially in developing regions with limited healthcare budgets. This poses a challenge for market growth, particularly in resource-constrained settings.

Market Drivers

  1. Increasing prevalence of infections: The rising prevalence of infections, including hospital-acquired infections and community-acquired infections, is a key driver of the sepsis diagnostics market. Infections can lead to sepsis, necessitating early and accurate diagnosis for effective management and treatment.
  2. Technological advancements in diagnostic techniques: The market is driven by continuous advancements in diagnostic techniques such as molecular diagnostics, flow cytometry, and immunoassays. These advancements enable rapid and accurate identification of pathogens responsible for sepsis, aiding in timely diagnosis and treatment.
  3. Growing awareness about sepsis: There has been a significant increase in awareness about sepsis among healthcare professionals, leading to improved diagnosis rates. Efforts by organizations and government bodies to educate healthcare providers and the general public about sepsis have contributed to the demand for diagnostic tools and tests.

Market Restraints

  1. High cost of diagnostic tests: The high cost of sepsis diagnostic tests can limit their adoption, especially in low-resource settings. The cost of advanced diagnostic techniques, reagents, and instruments may pose a financial burden on healthcare facilities, hindering market growth.
  2. Lack of skilled professionals: The accurate diagnosis of sepsis requires skilled laboratory professionals and clinicians. However, there is a shortage of trained professionals in certain regions, particularly in developing countries. This shortage of skilled personnel can impede the widespread adoption of sepsis diagnostic tools and tests.

Market Opportunities

  1. Point-of-care testing: The growing demand for rapid and accurate sepsis diagnosis has created opportunities for point-of-care testing. Point-of-care tests provide quick results at the bedside, enabling early intervention and timely treatment. Manufacturers are focusing on developing portable and user-friendly point-of-care diagnostic devices to cater to this demand.
  2. Emerging markets: The sepsis diagnostics market offers significant growth potential in emerging markets. These regions have a high burden of infectious diseases and are witnessing an increase in healthcare expenditure. Governments and healthcare organizations in these regions are investing in improving healthcare infrastructure, including diagnostic facilities, creating opportunities for market players.

Market Dynamics

The global sepsis diagnostics market is characterized by intense competition among key players. The market is driven by technological advancements, increasing awareness about sepsis, and the need for accurate and timely diagnosis. However, challenges such as the high cost of diagnostic tests and the shortage of skilled professionals pose obstacles to market growth. Strategic collaborations, product innovations, and geographic expansion are key strategies adopted by market players to gain a competitive edge.

Regional Analysis

The sepsis diagnostics market is segmented into several regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest share in the market, driven by advanced healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies. Europe follows closely, with a significant market presence. The Asia Pacific region is expected to witness substantial growth due to the increasing prevalence of infections, improving healthcare infrastructure, and rising awareness about sepsis.

Competitive Landscape

The global sepsis diagnostics market is highly competitive, with several players vying for market share. Some of the key players in the market include bioMérieux SA, Beckman Coulter, Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., and Abbott Laboratories. These companies focus on product launches, collaborations, and acquisitions to strengthen their market position. Continuous investments in research and development activities to develop innovative diagnostic tools and tests are also observed among market players.


The sepsis diagnostics market can be segmented based on diagnostic method, product type, technology, pathogen type, and end-user. Diagnostic methods include microbiological diagnostics, molecular diagnostics, immunoassays, flow cytometry, and others. Product types comprise instruments, reagents, and blood culture media. Technology-based segmentation includes polymerase chain reaction (PCR), microarrays, immunoassays, and others. Pathogen type categorizes the market into bacterial sepsis, fungal sepsis, and others. End-users of sepsis diagnostic products include hospitals, diagnostic laboratories, and others.

Category-wise Insights

  1. Diagnostic methods:
    • Microbiological diagnostics: Microbiological diagnostics involve culturing and identifying pathogens causing sepsis. This category includes blood culture tests and other culture-based techniques.
    • Molecular diagnostics: Molecular diagnostics utilize techniques such as polymerase chain reaction (PCR) to detect and identify genetic material from pathogens. These tests provide rapid and accurate results, aiding in early sepsis diagnosis.
    • Immunoassays: Immunoassays detect specific antibodies or antigens in the patient’s blood to diagnose sepsis. These tests are commonly used for the detection of sepsis biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT).
    • Flow cytometry: Flow cytometry is a technique used to analyze and quantify cells and particles. In sepsis diagnostics, flow cytometry can be used to detect changes in immune cell populations and identify markers of sepsis.
  2. Product types:
    • Instruments: Instruments used in sepsis diagnostics include automated blood culture systems, PCR machines, immunoassay analyzers, and flow cytometers. These instruments are essential for accurate and efficient diagnosis.
    • Reagents: Reagents are substances used in diagnostic tests to facilitate the detection of pathogens or biomarkers. They include culture media, PCR reagents, immunoassay reagents, and antibody-based reagents.
  3. Technology:
    • Polymerase chain reaction (PCR): PCR is a widely used molecular diagnostic technique that amplifies specific DNA sequences to detect pathogens causing sepsis.
    • Microarrays: Microarrays enable the simultaneous detection of multiple pathogens or genetic targets in a single test. They can be used for rapid and comprehensive sepsis diagnosis.
    • Immunoassays: Immunoassays detect antibodies or antigens associated with sepsis. They are commonly used for the detection of sepsis biomarkers and provide rapid results.
  4. Pathogen type:
    • Bacterial sepsis: Bacterial sepsis is the most common form of sepsis, caused by bacterial infections. It requires accurate identification of the bacteria causing the infection for targeted treatment.
    • Fungal sepsis: Fungal sepsis is caused by fungal infections and is more challenging to diagnose compared to bacterial sepsis. Molecular diagnostics and blood culture techniques are commonly used for the diagnosis of fungal sepsis.
  5. End-users:
    • Hospitals: Hospitals are the primary end-users of sepsis diagnostic products. The availability of diagnostic facilities within hospitals enables timely diagnosis and treatment of sepsis.
    • Diagnostic laboratories: Diagnostic laboratories play a crucial role in sepsis diagnosis. They perform a variety of tests, including blood cultures, molecular tests, and immunoassays, to detect pathogens and biomarkers associated with sepsis.

Key Benefits for Industry Participants and Stakeholders

  1. Improved patient outcomes: Accurate and timely diagnosis of sepsis enables prompt initiation of appropriate treatment, leading to improved patient outcomes and reduced mortality rates.
  2. Enhanced antibiotic stewardship: Effective sepsis diagnostics help in the targeted use of antibiotics, preventing the misuse and overuse of these drugs. This contributes to better antibiotic stewardship and helps in combating antibiotic resistance.
  3. Market growth opportunities: The growing demand for sepsis diagnostic tools and tests presents market players with opportunities for revenue generation and market expansion. The introduction of innovative technologies and products can help companies gain a competitive advantage.
  4. Research and development: The sepsis diagnostics market offers a platform for research and development activities aimed at improving diagnostic techniques, identifying new biomarkers, and developing novel diagnostic products. Industry participants can contribute to advancements in sepsis diagnostics through research collaborations and product innovation.

SWOT Analysis

  1. Strengths:
    • Technological advancements in diagnostic techniques
    • Increasing awareness about sepsis and its diagnostic methods
    • Growing demand for rapid and accurate sepsis diagnosis
  2. Weaknesses:
    • High cost of diagnostic tests
    • Shortage of skilled professionals in certain regions
  3. Opportunities:
    • Point-of-care testing for sepsis diagnosis
    • Emerging markets with a high burden of infectious diseases
  4. Threats:
    • Competition among market players
    • Stringent regulatory requirements for diagnostic products

Market Key Trends

  1. Integration of artificial intelligence: Artificial intelligence (AI) and machine learning algorithms are being incorporated into sepsis diagnostic tools to improve accuracy and speed of diagnosis. AI can analyze large datasets and assist clinicians in making informed decisions.
  2. Biomarkers for sepsis diagnosis: Research is focused on identifying new biomarkers that can aid in the early and accurate diagnosis of sepsis. Biomarkers such as procalcitonin, interleukins, and cell surface markers are being investigated for their diagnostic potential.
  3. Multiplex diagnostic assays: Multiplex assays that can simultaneously detect multiple pathogens or biomarkers associated with sepsis are gaining popularity. These assays offer increased efficiency and cost-effectiveness in sepsis diagnosis.
  4. Mobile applications for sepsis management: Mobile applications and digital platforms are being developed to facilitate sepsis management. These applications provide guidelines, decision support tools, and real-time monitoring of patients, enhancing sepsis care.

Covid-19 Impact

The COVID-19 pandemic has had a significant impact on the sepsis diagnostics market. The increased focus on infectious diseases and the importance of early diagnosis and management have highlighted the need for sepsis diagnostics. The pandemic has also led to advancements in diagnostic techniques, including rapid molecular tests and point-of-care devices, which have the potential to benefit sepsis diagnosis. However, the diversion of healthcare resources to COVID-19-related activities and the disruption of healthcare services have affected the overall diagnosis and management of sepsis.

Key Industry Developments

  1. Introduction of rapid diagnostic tests: Several companies have launched rapid diagnostic tests for sepsis, providing quick results and enabling early intervention. These tests utilize advanced technologies such as molecular diagnostics and immunoassays.
  2. Collaborations and partnerships: Market players are forming strategic collaborations and partnerships to enhance their product portfolios and expand their geographic presence. Collaborations between diagnostic companies and healthcare organizations aim to develop innovative sepsis diagnostic solutions.
  3. Technological advancements: Continuous technological advancements are being made in sepsis diagnostics, including the integration of AI, the development of novel biomarkers, and the introduction of portable and user-friendly diagnostic devices.

Analyst Suggestions

  1. Focus on cost-effective solutions: Companies should invest in the development of cost-effective diagnostic solutions to overcome the barrier of high costs associated with sepsis diagnosis. Affordable diagnostic tests and instruments can facilitate wider adoption, particularly in resource-limited settings.
  2. Training and education programs: Addressing the shortage of skilled professionals requires investment in training and education programs. Companies can collaborate with educational institutions and healthcare organizations to provide training on sepsis diagnostics and build a skilled workforce.
  3. Embrace digital technologies: Companies should leverage digital technologies such as mobile applications and telemedicine platforms to enhance sepsis management and facilitate remote monitoring of patients. These technologies can improve patient outcomes and streamline healthcare delivery.

Future Outlook

The global sepsis diagnostics market is expected to witness steady growth in the coming years. Factors such as the increasing prevalence of sepsis, technological advancements, and growing awareness about sepsis diagnostics will drive market expansion. The development of innovative diagnostic tools, the integration of AI, and the discovery of novel biomarkers will shape the future of sepsis diagnostics. Additionally, the market will continue to benefit from the emergence of point-of-care testing and the opportunities presented by emerging markets.


The global sepsis diagnostics market is witnessing significant growth, driven by the increasing incidence of sepsis cases and the demand for early and accurate diagnosis. Technological advancements, growing awareness, and the need for improved patient outcomes are key factors contributing to market expansion. However, challenges such as the high cost of diagnostic tests and the shortage of skilled professionals need to be addressed. Strategic collaborations, product innovation, and the focus on emerging markets are crucial for market players to stay competitive and capitalize on growth opportunities. The future of sepsis diagnostics holds promise with the integration of AI, the discovery of novel biomarkers, and the development of cost-effective solutions to address global sepsis burden.

Global Sepsis Diagnostics Market

Segmentation Details
Technology Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Others
Product Instruments, Reagents & Kits
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Leading Companies in the Global Sepsis Diagnostics Market:

  1. bioMérieux SA
  2. Thermo Fisher Scientific Inc.
  3. Becton, Dickinson and Company
  4. Abbott Laboratories
  5. Roche Diagnostics (F. Hoffmann-La Roche Ltd)
  6. Beckman Coulter, Inc. (Danaher Corporation)
  7. T2 Biosystems, Inc.
  8. Luminex Corporation
  9. Response Biomedical Corp. (Orchard Therapeutics plc)
  10. GenMark Diagnostics, Inc.

North America
o US
o Canada
o Mexico

o Germany
o Italy
o France
o UK
o Spain
o Denmark
o Sweden
o Austria
o Belgium
o Finland
o Turkey
o Poland
o Russia
o Greece
o Switzerland
o Netherlands
o Norway
o Portugal
o Rest of Europe

Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Kazakhstan
o Taiwan
o Vietnam
o Thailand
o Philippines
o Singapore
o Australia
o New Zealand
o Rest of Asia Pacific

South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America

The Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Israel
o Kuwait
o Oman
o North Africa
o West Africa
o Rest of MEA

Important Questions Covered in this Study

Why Choose MWR ?

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations.

Unlimited User Access

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions.

Free Company Inclusion

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges.

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met.

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis.

Client Associated with us


This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

Client Testimonials


This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

error: Content is protected !!
Scroll to Top

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF
This website is safe and your personal information will be secured. Privacy Policy
Request for Discount
This website is safe and your personal information will be secured. Privacy Policy
Speak to Analyst
This website is safe and your personal information will be secured. Privacy Policy

Download Free Sample PDF